We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-0.96%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$8.87B
AUM Growth
+$371M
Cap. Flow
+$510M
Cap. Flow %
5.75%
Top 10 Hldgs %
20.44%
Holding
2,307
New
202
Increased
1,106
Reduced
768
Closed
169

Sector Composition

Rank Sector Weight
1 Technology 5.47%
2 Financials 4.99%
3 Healthcare 3.94%
4 Industrials 3.75%
5 Consumer Discretionary 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMSA
2101
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$43K ﹤0.01%
+10,000
New +$50.3K
NAVB
2102
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$42K ﹤0.01%
5,819
+270
+5% +$2.02K
WPRT
2103
Westport Fuel Systems
WPRT
$36.7M
$41K ﹤0.01%
1,882
+446
+31% +$13.5K
WFT
2104
DELISTED
Weatherford International plc
WFT
$41K ﹤0.01%
17,691
+3,539
+25% +$11.3K
BAC.WS.B
2105
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
$40K ﹤0.01%
20,000
PLM
2106
DELISTED
PolyMet Mining Corp.
PLM
$40K ﹤0.01%
4,609
+1,250
+37% +$13.8K
MEET
2107
DELISTED
The Meet Group, Inc. Common Stock
MEET
$37K ﹤0.01%
17,653
-2,088
-11% -$5.42K
NVAX icon
2108
Novavax
NVAX
$1.31B
$33K ﹤0.01%
+784
New +$31.5K
ACGN
2109
DELISTED
Aceragen Inc
ACGN
$33K ﹤0.01%
132
UQM
2110
DELISTED
UQM Technologies, Inc.
UQM
$33K ﹤0.01%
25,869
-245
-0.9% -$332
VIVS
2111
VivoSim Labs
VIVS
$1.23M
$32K ﹤0.01%
129
-248
-66% -$72.3K
TLPH icon
2112
Talphera
TLPH
$76.3M
$31K ﹤0.01%
734
PLUG icon
2113
Plug Power
PLUG
$3.1B
$30K ﹤0.01%
15,851
-2,380
-13% -$4.79K
CRNT icon
2114
Ceragon Networks
CRNT
$199M
$29K ﹤0.01%
10,735
SDLP
2115
DELISTED
SEADRILL PARTNERS LLC
SDLP
$29K ﹤0.01%
1,065
WIN
2116
DELISTED
Windstream Holdings Inc
WIN
$28K ﹤0.01%
3,920
-2,631
-40% -$21.4K
HMY icon
2117
Harmony Gold Mining
HMY
$12.2B
$25K ﹤0.01%
10,329
-467
-4% -$930
ALIM
2118
DELISTED
Alimera Sciences
ALIM
$25K ﹤0.01%
1,587
EXK
2119
Endeavour Silver
EXK
$3.14B
$24K ﹤0.01%
10,010
TURN
2120
DELISTED
180 Degree Capital
TURN
$24K ﹤0.01%
4,308
ATHX
2121
DELISTED
Athersys, Inc. Common Stock
ATHX
$23K ﹤0.01%
512
+40
+8% +$1.73K
HOV icon
2122
Hovnanian Enterprises
HOV
$805M
$22K ﹤0.01%
474
IDXG
2123
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$20K ﹤0.01%
2,260
LINU
2124
DELISTED
LiNiu Technology Group Ordinary Shares
LINU
$18K ﹤0.01%
+12,334
New +$21.6K
CRIS icon
2125
Curis
CRIS
$4.5M
$15K ﹤0.01%
+11
New +$14.4K

Similar funds

Cambridge Investment Research Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Cambridge Investment Research Advisors held 2,307 positions worth $8.87B, up 4.4% from $8.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $510M of net new capital in Q1 2018, opening 202 new positions and adding to 1,106 existing holdings. Its largest new stake was BrightSpire Capital: 489,150 shares worth $9.27M.

By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 5.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $24.6M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2018 buy was BrightSpire Capital: 489,150 shares worth $9.27M.
  • Cambridge Investment Research Advisors added most to iShares S&P Mid-Cap 400 Growth ETF in Q1 2018, an estimated $21.9M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $24.6M.
  • Cambridge Investment Research Advisors fully exited KB Financial Group in Q1 2018, selling an estimated $3.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $8.87B portfolio in Q1 2018.
  • Cambridge Investment Research Advisors opened 202 new positions and closed 169 in Q1 2018.
  • Cambridge Investment Research Advisors's portfolio value rose 4.4% quarter-over-quarter to $8.87B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.